Prevalence of Women in the US Who Have Never Underwent Cervical Cancer Screening

Overview

This study evaluates the increase in the prevalence of women in the US who have never undergone cervical cancer screening from 2005 to 2023, highlighting disparities among different age groups.

Background

Cervical cancer is largely preventable through effective screening programs; however, many women remain unscreened. Identifying women who have never been screened is crucial for addressing gaps in preventive care, especially for younger women who are newly eligible for screening.

Data Highlights

Key Findings

• The percentage of women aged 21 to 29 years who had never undergone cervical cancer screening rose from 12.5% in 2005 to 31.9% in 2023.
• For women aged 30 to 65 years, the proportion never screened increased from 5.3% in 2005 to 14.8% in 2023.
• HPV vaccination rates among women aged 21 to 29 years increased from 5.7% in 2008 to 54.0% in 2019.
• Significant increases in cervical cancer incidence were observed among women aged 30 to 64 years, particularly in regional and distant stages after 2017.
• Joinpoint regression analysis revealed an annual percentage change in nonscreening rates from 2010 to 2023.

Clinical Implications

The rising prevalence of never-screened women highlights the need for targeted outreach and education to improve cervical cancer screening rates, especially among younger populations. Healthcare providers should prioritize discussions around screening and HPV vaccination to mitigate future cervical cancer risks.

Conclusion

The study underscores a troubling trend in cervical cancer screening rates among US women, particularly in younger age groups, necessitating urgent public health interventions.

Related Resources & Content

1. Rates of Never Receiving Cervical Cancer Screening Among US Women, 2005-2023 | Women's Health | JAMA Network Open, 2023 -- Title
2. the pathologist — Steps Forward in Cancer Screening
3. MDSpire News — Women Overdue for Cancer Screenings
4. JAMA Network Open — Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years
5. jadpro — Predictors of Cervical Cancer Screening Adherence in the United States: A Systematic Review
6. Final Recommendation Statement: Cervical Cancer: Screening | United States Preventive Services Taskforce
7. Draft Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce
8. cobas HPV Test for 4800 System – P100020/S055 | FDA
9. Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee - PMC
10. Rates of Never Receiving Cervical Cancer Screening Among US Women, 2005-2023 | Women's Health | JAMA Network Open | JAMA Network